Boundless Bio insider buys 57,210 shares
Boundless Bio, Inc. reported that entities associated with Tang Capital Partners made open-market purchases of a total of 57,210 shares of common stock over three days.
Rhea-AI Filing Summary
Boundless Bio, Inc. reported that entities associated with Tang Capital Partners made open-market purchases of a total of 57,210 shares of common stock over three days. The buys on July 6–8, 2026 were executed at weighted-average prices between $2.46 and $2.49 per share.
Following these transactions, the indirect holdings reported as "By LP" increased to 2,698,518 shares of Boundless Bio common stock. Footnotes state that various Tang Capital funds collectively beneficially own these shares and that Kevin Tang has a pecuniary interest in the positions.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 14,338 | $2.46 | $35K |
| Purchase | Common Stock | 15,810 | $2.48 | $39K |
| Purchase | Common Stock | 27,062 | $2.49 | $67K |
Footnotes (4)
- F1. The prices reported are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $2.46 to $2.50. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC staff, upon request, all information regarding the number of shares purchased at each price within the ranges set forth in Footnotes 1 and 3 through 4.
- F2. Tang Capital Partners, LP ("TCP") beneficially owns 618,407 shares, Tang Capital Partners International, LP ("TCPI") beneficially owns 843,301 shares, Tang Capital Partners III, Inc. ("TCP III") beneficially owns 618,403 shares, and Tang Capital Partners IV, Inc. ("TCP IV") beneficially owns 618,407 shares. Kevin Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP and TCPI. Kevin Tang is the sole director and Chief Executive Officer of TCP III and TCP IV, which are indirectly wholly owned by TCP. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP, TCPI, TCP III and TCP IV.
- F3. These shares were purchased in multiple transactions at prices ranging from $2.44 to $2.50.
- F4. These shares were purchased in multiple transactions at prices ranging from $2.42 to $2.48.
Key Figures
Key Terms
open-market purchase financial
weighted-average prices financial
beneficially owns financial
pecuniary interest financial
indirect ownership financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider activity did Boundless Bio (BOLD) report in this Form 4?
Who is the reporting person in the Boundless Bio (BOLD) Form 4 filing?
What is the total Boundless Bio (BOLD) stake after these insider purchases?
How are the Boundless Bio (BOLD) insider purchases held, direct or indirect?
Over what dates did the Boundless Bio (BOLD) insider purchases occur?
AI-generated analysis. How Rhea-AI works. Not financial advice.